Greater Cannabis Company Inc (GCAN)
Greater Cannabis Company Inc. (OTC-GCAN) is a common stock listing on OTC Markets for a healthcare company focused on the development and commercialization of cannabinoid-based therapeutics. The company has described an oral transmucosal patch platform designed to deliver active ingredients through the buccal mucosa. It also has a license agreement with Shaare Zedek Scientific Ltd. related to research and treatment areas including autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. Founded in 2014, Greater Cannabis Company is based in Baltimore, Maryland.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-GCAN
|
Not available
|
Not available
|
Not available
|
Great
|
0.0%
|
November 12, 2026
|
2.7x
|
467.356 K
|
2.344 M
|
0.0%
|
93.3%
|
-59,735.7
|
-4.6%
|
